PRESS RELEASE published on 06/03/2024 at 08:40, 1 year 11 months ago DATE DE PUBLICATION DES RESULTATS ANNUELS 2023 Le Groupe AURES annonce la publication de ses résultats annuels 2023 ce jeudi 6 juin 2024 après bourse. AURES Technologies est un développeur et constructeur informatique de solutions matérielles pour le point de vente Résultats Annuels Euronext Growth Groupe AURES POS Développeur Informatique
BRIEF published on 04/30/2024 at 19:50, 2 years ago Postponement of the publication of AURES TECHNOLOGIES' 2023 annual results Acquisition Funding Annual Results Report OTHER TECHNOLOGIES
BRIEF published on 04/30/2024 at 19:50, 2 years ago Report de la publication des résultats annuels 2023 d’AURES TECHNOLOGIES Acquisition Financement Résultats Annuels Report AURES Technologies
PRESS RELEASE published on 04/30/2024 at 19:45, 2 years ago REPORT DE PUBLICATION AURES annonce le report de la publication de ses résultats annuels 2023 en raison de négociations exclusives et d'une offre publique d'achat. Les résultats devraient être publiés semaine 22 Négociations Exclusives Offre Publique D'achat Résultats Annuels Report AURES
BRIEF published on 04/22/2024 at 08:05, 2 years 1 month ago AURES Initiates Exclusive Negotiation with Advantech and Founder for Strategic Acquisition Convertible Bonds Exclusive Negotiations Tender Offer AURES Technologies Advantech
BRIEF published on 04/22/2024 at 08:05, 2 years 1 month ago AURES entame des négociations exclusives avec Advantech et son fondateur pour une acquisition stratégique Négociations Exclusives Offre Publique D'achat Liens Convertibles AURES Technologies Advantech
PRESS RELEASE published on 04/22/2024 at 08:00, 2 years 1 month ago AURES : ENTREE EN NEGOCIATIONS EXCLUSIVES Négociations exclusives pour financement et acquisition chez AURES entre Advantech et Patrick Cathala, incluant offre publique d'achat. Opération pour renforcer l'Emetteur avec les technologies AIoT Acquisition Négociations Exclusives Offre Publique D'achat Advantech AURES
PRESS RELEASE published on 04/22/2024 at 08:00, 2 years 1 month ago AURES : ENTRY INTO EXCLUSIVE NEGOCIATIONS AURES, Advantech, and Patrick Cathala enter exclusive negotiations for a fund and acquisition deal followed by a mandatory cash tender offer, aiming to boost resources and global presence Global Presence Exclusive Negotiations Cash Tender Offer Advantech AURES
Published on 05/23/2026 at 19:45, 9 hours 58 minutes ago Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 1 day 2 hours ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 1 day 2 hours ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 1 day 3 hours ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 1 day 3 hours ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/24/2026 at 05:35, 7 minutes ago CGTN: Xizang at 75: Development and culture create a 'miracle on Earth'
Published on 05/23/2026 at 16:30, 13 hours 12 minutes ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 13 hours 46 minutes ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 1 day 7 hours ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 1 day 7 hours ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:35, 1 day 10 hours ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 11 hours ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 11 hours ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 16 hours ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 16 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
